These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22578270)

  • 1. Dyslipidemia and its therapeutic challenges in renal transplantation.
    Riella LV; Gabardi S; Chandraker A
    Am J Transplant; 2012 Aug; 12(8):1975-82. PubMed ID: 22578270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Davidson M
    Prev Cardiol; 2005; 8(4):244-9. PubMed ID: 16230879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
    Ahmed MH; Khalil AA
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of statins on cardiovascular outcomes in renal transplant recipients: a systematic review.
    Maharjan N; Bedi U; Arora R; Bhandari S; Dahal P; Khosla S
    Am J Ther; 2011 May; 18(3):e48-54. PubMed ID: 21048435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin.
    Pandian A; Arora A; Sperling LS; Khan BV
    Vasc Health Risk Manag; 2008; 4(5):1001-9. PubMed ID: 19183748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current guidelines for treatment of dyslipidemia in kidney diseases].
    Jędras M; Dylewska M
    Wiad Lek; 2014; 67(3):426-8. PubMed ID: 25782205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What combination therapy with a statin, if any, would you recommend?
    Dujovne CA; Williams CD; Ito MK
    Curr Atheroscler Rep; 2011 Feb; 13(1):12-22. PubMed ID: 21107758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors and the kidney.
    Campese VM; Hadaya B; Chiu J
    Curr Hypertens Rep; 2005 Oct; 7(5):337-42. PubMed ID: 16157074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia treatment and cardiovascular disease in the renal patient.
    Burst V; Benzing T
    Curr Pharm Des; 2011; 17(9):894-907. PubMed ID: 21418028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of dyslipidemia in patients with metabolic syndrome and chronic kidney disease].
    Monhart V
    Vnitr Lek; 2009; 55(7-8):671-8. PubMed ID: 19731874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Corsini A; Holdaas H
    Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dyslipidemia in patients with chronic kidney disease.
    Marino A; Tannock LR
    Postgrad Med; 2013 Jul; 125(4):28-37. PubMed ID: 23842535
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.
    Kondo Y; Hamai J; Nezu U; Shigematsu E; Kamiko K; Yamazaki S; Yoshii T; Takahashi M; Takano T; Kawasaki S; Yamada M; Yamakawa T; Terauchi Y
    Endocr J; 2014; 61(4):343-51. PubMed ID: 24452015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.